Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Luke Miels
Pharma
GSK revs up launch plans after Nucala's FDA approval in COPD
The thumbs-up makes Nucala the second biologic approved in COPD and the third new therapy cleared for the disease by the FDA in less than a year.
Fraiser Kansteiner
May 22, 2025 3:10pm
GSK cuts Shingrix deliveries in revised Zhifei China pact
Dec 5, 2024 10:52am
GSK's RSV vaccine sales plummet in wake of guidance changes
Oct 30, 2024 10:41am
GSK cuts 2024 vaccines sales amid CDC's narrowed RSV policy
Jul 31, 2024 10:13am
GSK readopts £3B peak sales estimate for myeloma ADC Blenrep
Jun 17, 2024 3:22pm
GSK reports blockbuster sales for Arexvy in RSV race vs. Pfizer
Jan 31, 2024 9:50am
